Effects of the selective inhibition of proteasome caspase-like activity by CLi a derivative of nor-cerpegin in dystrophic mdx mice

Archive ouverte

Hovhannisyan, Yeranuhi | Melikyan, Gagik | Mougenot, Nathalie | Gao-Li, Jacqueline | Friguet, Bertrand | Paulin, Denise | Li, Zhenlin | Ferry, Arnaud | Agbulut, Onnik

Edité par CCSD ; Public Library of Science -

International audience. Previous studies have shown that proteasome inhibition can have beneficial effects in dys-trophic mouse models. In this study, we have investigated the effects of a new selective pro-teasome inhibitor, CLi, a strong caspase-like inhibitor of the 20S proteasome, on skeletal and cardiac muscle functions of mdx mice. In the first series of experiments, five-month-old male mdx mice (n = 34) were treated with 2 different doses (20 and 100 μg/kg) of CLi and in the second series of experiments, five-month-old female mdx (n = 19) and wild-type (n = 24) mice were treated with 20 μg/kg CLi and Velcade (1 mg/kg) for 1-month. All animals were treadmill exercised twice a week to worsen the dystrophic features. In the first series of experiments, our results demonstrated that 20 μg/kg CLi did not significantly increase absolute and specific maximal forces in skeletal muscle from male mdx mice. Moreover, the higher susceptibility to contraction induced skeletal muscle injury was worsened by 100 μg/ kg CLi since the force drop following lengthening contractions was increased with this high dose. Furthermore, we found no differences in the mRNA levels of the molecular markers implicated in dystrophic features. Concerning cardiac function, CLi had no effect on left ven-tricular function since ejection and shortening fractions were unchanged in male mdx mice. Similarly, CLi did not modify the expression of genes implicated in cardiac remodeling. In the second series of experiments, our results demonstrated an improvement in absolute and specific maximal forces by CLi, whereas Velcade only increased specific maximal force in female mdx mice. In addition, exercise tolerance was not improved by CLi. Taken together, our results show that CLi treatment can only improve maximal force production in exercised female mdx mice without affecting either exercice tolerance capacity or cardiac function. In conclusion, selective inhibition of caspase-like activity of proteasome with CLi has no compelling beneficial effect in dystrophic mdx mice.

Suggestions

Du même auteur

Effects of the selective inhibition of proteasome caspase-like activity by CLi a derivative of nor-cerpegin in dystrophic mdx mice

Archive ouverte | Hovhannisyan, Yeranuhi | CCSD

International audience

Absence of desmin results in impaired adaptive response to mechanical overloading of skeletal muscle

Archive ouverte | Joanne, Pierre | CCSD

International audience. Background: Desmin is a muscle-specific protein belonging to the intermediate filament family. Desmin mutations are linked to skeletal muscle defects, including inherited myopathies with seve...

Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy

Archive ouverte | Li, Zhenlin | CCSD

International audience. Synemin, a type IV intermediate filament (IF) protein, forms a bridge between IFs and cellular membranes. As an A-kinase-anchoring protein, it also provides temporal and spatial targeting of ...

Chargement des enrichissements...